Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC

Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC

In lung cancer immunotherapy, biomarkers to guide clinical decisions are limited. We now explore whether the detailed immunophenotyping of circulating peripheral blood mononuclear cells (PBMCs) can predict the efficacy of anti-PD-1 immunotherapy in patients with advanced non-small-cell lung cancer (...

Full description

Bibliographic Details
Main Authors: Jacobo Rogado, Fernando Pozo, Kevin Troule, José Miguel Sánchez-Torres, Nuria Romero-Laorden, Rebeca Mondejar, Olga Donnay, Anabel Ballesteros, Vilma Pacheco-Barcia, Javier Aspa, Fátima Al-Shahrour, Arantzazu Alfranca, Ramon Colomer
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
non-small cell lung cancer
anti-PD-1 antibodies
immunotherapy
biomarkers
peripheral blood mononuclear cells
Online Access:https://www.mdpi.com/2072-6694/14/12/2898

Internet

https://www.mdpi.com/2072-6694/14/12/2898

Similar Items